Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Human Monoclonal MUC1 Primary Antibody pour ELISA, ICC - ABIN266893
Dalziel, Whitehouse, McFarlane, Brockhausen, Gschmeissner, Schwientek, Clausen, Burchell, Taylor-Papadimitriou: The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. dans The Journal of biological chemistry 2001
Show all 11 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour IHC (f), IHC (fro) - ABIN2689099
Agrawal, Schatz: RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. dans Cell 1997
Show all 6 Pubmed References
Human Polyclonal MUC1 Primary Antibody pour ICC, IF - ABIN5631320
Nallasamy, Li, Bagchi, Bagchi: Msx homeobox genes critically regulate embryo implantation by controlling paracrine signaling between uterine stroma and epithelium. dans PLoS genetics 2012
Show all 5 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour ICC, FACS - ABIN335355
Gourevitch, von Mensdorff-Pouilly, Litvinov, Kenemans, van Kamp, Verstraeten, Hilgers: Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. dans British journal of cancer 1995
Show all 3 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour IHC (fro), IHC (p) - ABIN966067
Hilkens, Buijs, Hilgers, Hageman, Calafat, Sonnenberg, van der Valk: Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. dans International journal of cancer. Journal international du cancer 1984
Show all 2 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour FACS, IHC (fro) - ABIN2479333
Gill: Brittle diabetes: a report of the First International Conference on Brittle Diabetes. dans Diabetic medicine : a journal of the British Diabetic Association 1992
Show all 4 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour IHC (fro), IHC (p) - ABIN2479332
Kennedy, Darne, Cohn, Price, Davies, Blumsohn, Griffiths: Human chorionic gonadotropin may not be responsible for thyroid-stimulating activity in normal pregnancy serum. dans The Journal of clinical endocrinology and metabolism 1992
Show all 4 Pubmed References
Human Monoclonal MUC1 Primary Antibody pour ELISA, WB - ABIN518080
Desmetz, Bascoul-Mollevi, Rochaix, Lamy, Kramar, Rouanet, Maudelonde, Mangé, Solassol: Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. dans Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Human Polyclonal MUC1 Primary Antibody pour IF (p), IHC (p) - ABIN687367
Taki, Ohmuraya, Tanji, Komatsu, Hashimoto, Semba, Araki, Kawaguchi, Baba, Furukawa: GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm. dans Oncogene 2016
Frameshift mutation in MUC1 is associated with autosomal dominant tubulointerstitial kidney disease.
MUC1 up-regulation is associated with castration-resistant prostate cancer and bone metastasis.
As MUC1 and galectin-3 (Montrer LGALS3 Anticorps) are both commonly overexpressed in most types of epithelial cancers, their interaction and impact on EGFR (Montrer EGFR Anticorps) activation likely makes important contribution to EGFR (Montrer EGFR Anticorps)-associated tumorigenesis and cancer progression.
Results identified MUC1 as a novel target of 14-3-3zeta (Montrer YWHAZ Anticorps) in lung adenocarcinoma. Its high expression is associated with poor survival in lung adenocarcinoma patients.
In malignant epithelial ovarian tumors, the positive expression rates of Lewis(y) antigen and MUC1 were 88.33 and 86.67%, respectively, which were markedly higher than those in borderline (60.00 and 53.33%, P<0.05), benign (33.33 and 30%, P<0.01) and normal (0 and 25%, P<0.01) ovarian samples.
In uninflamed CD ileum and IBD colon, most barrier gene levels restored to normal, except for MUC1 and MUC4 (Montrer MUC4 Anticorps) that remained persistently increased compared with controls. Genetic and transcriptomic dysregulations of key epithelial barrier genes and components in IBD. In particular MUC1 and MUC4 (Montrer MUC4 Anticorps), play an essential role in the pathogenesis of IBD and could represent interesting targets for treatment.
this study implicates the MUC1 as a critical and dynamic component of the innate host response that limits the severity of influenza and provides the foundation for exploration of MUC1 in resolving inflammatory
the observed G1 phase arrest completely agrees with the metabolomics results; MUC1-overexpressing cells under glucose limitation have an altered glutamine (Montrer GFPT1 Anticorps) metabolism that results in a disruption in de novo pyrimidine synthesis that negatively impacts DNA replication. Moreover, our results provide a clear explanation for the observed glucose dependency of MUC1-overexpressing cells.
Data suggest that ositive Mucin-1 (MUC1) expression in cell block cytology specimens may be associated with progressive dilation of the main and ectatic branches of pancreatic ducts.
In conclusion, this meta-analysis suggested that rs4245739 polymorphism in the MUC1 gene may play a pivotal role in the pathogenesis of GC, especially for white populations
The results indicate that Muc1 gene is significantly associated with litter size in pigs.
The epiblast expressed epithelial markers, MUC1 and E-CADHERIN (Montrer CDH1 Anticorps), and the pluripotency markers, DNMT3B (Montrer DNMT3B Anticorps) and CRIPTO (Montrer TDGF1 Anticorps).
Endometrial expressions of MUC1 and cytokine genes differed among normal, fertile versus diseased, and subfertile dairy cows.
Bovine Muc1 prevents binding of bacteria to human intestinal cells and may have a role in preventing the binding of common enteropathogenic bacteria to human intestinal epithelial surfaces.
concluded that bovine Muc1 protein is probably an inducible innate immune effector and an important component of the first line of defense against bacterial invasion of epithelial surfaces
this study implicates the MUC1 as a critical and dynamic component of the innate host response that limits the severity of influenza and provides the foundation for exploration of MUC1 in resolving inflammatory disease
Tumor growth delays observed by tumor irradiation combined with MVA (Montrer MYO5A Anticorps)-MUC1-IL-2 (Montrer IL2 Anticorps) vaccine were significantly more prolonged than those observed by vaccine, radiation, or radiation with MVA (Montrer MYO5A Anticorps) empty vector.
Muc1 has anti-fibrotic properties in the mouse lung.
our data suggest a novel molecular mechanism by which tMUC1 may modulate NRP1 (Montrer NRP1 Anticorps)-dependent VEGFR (Montrer KDR Anticorps) signaling in PDA cells.
Low expression of MUC1 is associated with lung carcinogenesis.
Using an extensive collection of novel murine cell lines we have identified distinct roles for Kras and Pten on MUC1 and EMT (Montrer ITK Anticorps) in vivo and in vitro. The data has implications for future design of combination therapies targeting Kras mutations, Pten deletions and MUC1 vaccines.
Gp91phox (Montrer CYBB Anticorps) NADPH oxidase (Montrer NOX1 Anticorps) modulates litter size by up-regulating mucin1 expression in the uterus of mice.
In summary, we have demonstrated that MUC1 on immune cells is a novel regulator of the NLRP3 (Montrer NLRP3 Anticorps) inflammasome, and propose this is mediated by an interaction with signalling components at the cytoplasmic domains of TLRs that involves inhibition of IRAK4 (Montrer IRAK4 Anticorps) activation.
MUC1 regulates IL-1beta (Montrer IL1B Anticorps) secretion induced by the NLRP3 (Montrer NLRP3 Anticorps)-activating bacteria Haemophilus influenzae but not bacteria that activate other inflammasomes.
Muc1 protection during acute kidney injury proceeds by enhancing both the HIF-1 (Montrer HIF1A Anticorps) and beta-catenin (Montrer CTNNB1 Anticorps) protective pathways.
This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.
, H23 antigen
, breast carcinoma-associated antigen DF3
, cancer antigen 15-3
, carcinoma-associated mucin
, krebs von den Lungen-6
, mucin 1, transmembrane
, peanut-reactive urinary mucin
, polymorphic epithelial mucin
, tumor associated epithelial mucin
, tumor-associated epithelial membrane antigen
, tumor-associated mucin
, endometrial mucin-1
, epithelial mucin